ArticleJournal of ginseng research2026
Ginsenoside Rh7 ameliorates myocardial injury in diabetic cardiomyopathy by promoting M2 polarization of macrophages via SIRT1/FOXO1/β-catenin.
Article in Journal of ginseng research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To investigate the intervention effect of ginsenoside Rh7 on myocardial dysfunction in diabetic cardiomyopathy. Methods: A diabetic cardiomyopathy (DCM) mouse model was established using a high-fat diet combined with streptozotocin (STZ), and treated with ginsenoside Rh7. Echocardiography was used to detect changes in cardiac function in mice. Mouse body weight, heart weight, and cardiac index were measured. H&E staining was used to detect pathological changes in the heart. Tissue chemistry and fluorescence staining were used to detect the expression of CD206 and SIRT1 in the heart. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of M1/M2 cell markers. Results: Rh7 can improve cardiac dysfunction in DCM mice by inhibiting the expression of SIRT1, thereby promoting the activation of the FOXO1/β-catenin complex and M2 polarization of macrophages.In vitro iBMDM experiments showed that Rh7 can promote CD206 expression and M2 polarization of macrophages. Small molecule-protein docking and pull-down experiments confirmed the binding relationship between Rh7 and SIRT1. Conclusion: Rh7 can ameliorate myocardial injury in DCM mice by inhibiting SIRT1 and activating FOXO1/β-catenin, thereby promoting M2 polarization of macrophages.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.